This Article Full Text Full Text (PDF) All Versions of this Article: 39/6/1703    most recent STROKEAHA.107.501759v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Czabanka, M. Articles by Schmiedek, P. PubMed PubMed Citation Articles by Czabanka, M. Articles by Schmiedek, P. Related Collections Brain Circulation and Metabolism Angiography By-pass procedures Transient Ischemic Attacks Other Stroke

(Stroke. 2008;39:1703.)
© 2008 American Heart Association, Inc.

Original Contributions

Characterization of Cortical Microvascularization in Adult Moyamoya Disease

Marcus Czabanka, MD; Pablo Peña-Tapia, MD; Gerrit A. Schubert, MD; Johannes Woitzik, MD; Peter Vajkoczy, MD Peter Schmiedek, MD

From the Department of Neurosurgery (M.C., P.P.-T., G.A.S., P.S.), Klinikum Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, and the Department of Neurosurgery (M.C., J.W., P.V.), Charité-Universitätsmedizin Berlin, Berlin, Germany.

Correspondence to Marcus Czabanka, MD, Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Am Augustenburgerplatz 1, 13353 Berlin, Germany. E-mail marcus.czabanka{at}charite.de

Background and Purpose— Increased cortical microvascularization has been proposed to be a Moyamoya disease (MMD)–specific characteristic. It was the aim of our study to characterize the anatomic pattern and microhemodynamics of cortical microvascularization in MMD.

Methods— Intraoperative indocyanine green videoangiography was performed in 16 adult MMD patients, 15 patients with atherosclerotic cerebrovascular disease (ACVD), and 10 control patients. Cortical microvascularization and microvascular hemodynamics were categorized and analyzed according to anatomic and functional indocyanine green angiographic aspects. Anatomic analysis included microvascular density, microvascular diameter, and microvascular surface per analyzed area. Microhemodynamic analysis included microvascular transit time, arterial microvascular transit time, and venous microvascular transit time.

Results— Microvascular density and diameter were significantly increased in MMD patients (1.8±0.2 mm/mm² and 0.24±0.03 mm, respectively) compared with those in ACVD patients (1.5±0.2 mm/mm² and 0.20±0.02 mm, respectively) and controls (1.5±0.1 mm/mm² and 0.19±0.03 mm, respectively). This resulted in significantly increased microvascular surface per analyzed area in MMD (67±13%) vs ACVD patients (47±7%) and controls (45±6%). Anatomic changes were paralleled by significantly increased microvascular and arterial microvascular transit times in MMD patients (11.55±3.50 and 6.79±2.96 seconds, respectively) compared with those in ACVD patients (8.13±1.78 and 4.34±1.30 seconds, respectively) and controls (8.04±2.16 and 4.50±1.87 seconds, respectively).

Conclusion— Cortical microvascularization in MMD is characterized by significantly increased microvascular density and microvascular diameter, leading to increased microvascular surface. These anatomic alterations are accompanied by prolonged microvascular hemodynamics. These observations might represent an MMD-specific compensation mechanism for impaired cerebral blood flow.

Key Words: Moyamoya disease • cortical vascularization • indocyanine green videoangiography • cerebral blood flow • compensation mechanism